pleural effusion
Conditions
Interventions
Gold Standard:cytological pathological testing
of 
(CAC)
Sponsors
Zhongshan Hospital, Fudan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Clinical diagnosis of patients with pleural effusion, concurrent pleural effusion drainage; 2. Aged >=18 years; 3. The subject's pleural effusion undergoes cytology, tumor marker (CEA) testing, and other routine, biochemical, ADA and other auxiliary diagnostic tests; 4. Agree to participate in this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Unable to puncture and drain pleural effusion; 2. Has received clinical therapeutic interventions related to lung cancer, such as surgery, radiotherapy, chemotherapy, targeted therapy, immunotherapy, etc.; 3. Local thoracic treatment, such as bevacizumab, lentinan, etc., has been performed within two weeks; 4. Due to sampling problems, it is unable to meet the research unit's pleural effusion cytological pathological testing requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| circulating abnormal cells; | — |
Countries
China
Contacts
Public ContactTONG LIN
Zhongshan Hospital, Fudan University
Outcome results
None listed